Strides, Orbicular sign pact to jointly develop a range of nasal sprays
Express Pharma
MAY 3, 2023
It has developed and licensed various complex injectables, topicals, ophthalmic, parenteral, nasal spray, and inhalation product assets. Orbicular will develop nasal sprays for global markets. Strides will commercialise these nasal sprays across the markets using its commercial engine in the US, Europe, and several other markets.
Let's personalize your content